4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas

Blood Cancer J. 2021 Mar 17;11(3):59. doi: 10.1038/s41408-021-00455-x.

Cheng Jiao^#^{1

2}, Eugene Zvonkov^#³, Xun Lai^#⁴, Rui Zhang¹, Yuchen Liu¹, Yue Qin⁵, Valery Savchenko³, Nelly Gabeeva³, Tsai-Hua Chung^{1

5}, Liyuan Sheng^{2

6}, Lung-Ji Chang^{7

8}

¹ Shenzhen Geno-Immune Medical Institute, 518000, Shenzhen, China.
² PKU-HKUST Shenzhen-Hong Kong Institution, 518057, Shenzhen, China.
³ National Research Center for Hematology, Moscow, 125167, Russia.
⁴ The Third Affiliated Hospital of Kunming Medical University, Cancer Hospital of Yunnan, 650118, Kunming, Yunnan, China.
⁵ University of Electronic Science and Technology of China, 611731, Chengdu, Sichuan, China.
⁶ Peking University, Shenzhen Institute, Shenzhen Key Lab Human Tissue Regenerate & Repair, 518057, Shenzhen, China.
⁷ Shenzhen Geno-Immune Medical Institute, 518000, Shenzhen, China. c@szgimi.org.
⁸ University of Electronic Science and Technology of China, 611731, Chengdu, Sichuan, China. c@szgimi.org.

^# Contributed equally.

No abstract available

Publication types